Trump Says Putin G-20 Visit Would ‘Probably Be Very Helpful’

Regeneron said it will invest $27 billion in U.S. pharmaceutical manufacturing, a sizable domestic expansion that supports future production capacity and supply-chain resilience. The announcement is constructive for the company and the healthcare manufacturing sector, though the article provides no details on timing, funding, or expected financial impact.

Analysis

Regeneron said it will invest $27 billion in U.S. pharmaceutical manufacturing, a sizable domestic expansion that supports future production capacity and supply-chain resilience. The announcement is constructive for the company and the healthcare manufacturing sector, though the article provides no details on timing, funding, or expected financial impact.